Abbott Delivers Strong Q2 Sales, Led By Spike In FreeStyle Libre Sales

Abbott delivered solid sales growth in the second quarter of 2019, topping analyst expectations. The company reported worldwide sales of $8bn, up 2.7% with Medical Devices highlighted as a standout division, delivering 10.5% organic growth.

SANTA CLARA, CA/USA - JULY 29, 2017: Abbott Laboratories exterior and logo. Abbott Laboratories is an American worldwide health care company. - Image

Abbott Laboratories Inc. has raised its full-year profit guidance following stronger-than-expected earnings in the second quarter of 2019.

During its earnings call on 17 July, Abbott reported its worldwide medical devices division was the strongest performer in the second quarter of 2019, including double-digit growth in sales of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diabetic Care

More from Device Area